A prospective study on tumour response assessment methods after neoadjuvant endocrine therapy in early oestrogen receptor-positive breast cancer

Table 2 Radiological (rad-) and pathological (path-) tumour response (TR) after NET

Rad-TR type [n (%)]	MRI	USS	Path-TR [n (%)]
N/A	7 (7)	14 (13)	0 (0)
Complete	27 (26)	16 (15)	1 (1)
Partial	40 (38)	49 (47)	76 (72)
Stable disease	29 (27)	24 (23)	28 (27)
Progressive disease	2 (2)	2 (2)	0 (0)

Rad-TR was evaluated by mRECIST 1.1 criteria, and path-TR was measured using a modified Miller and Payne grading scale. N/A not available

ISSN: 1465-542X